We are also concerned that the 14-day supply limit is burdensome for physicians and patients. To ease the burden, the refill process should follow the timeline of laboratory monitoring, meaning refills should be made at weeks 4, 8, and 12, as appropriate to the treatment regimen. Thank you for allowing Project Inform and the National Viral Hepatitis Roundtable the opportunity to comment on the draft HCV treatment policy and express our concerns about the proposed policy. Please contact us if you have questions or require additional information. We look forward to your response to our concerns. Sincerely, Emalie Huriaux, MPH Tina Broder, MSW, MPH Director of Federal & State Affairs Program Manager Project Inform National Viral Hepatitis Roundtable (415) 580-7301 (510) 336-9613 cc: Ryan Clary, Executive Director, National Viral Hepatitis Roundtable Anne Donnolly, Director of Health Care Policy, Project Inform Margaret Tater, DHCS Neal Kohatsu, DHCS Anastasia Dodson, DHCS Mari Cantwell, DHCS
We are also concerned that the 14-day supply limit is burdensome for physicians and patients. To ease the burden, the refill process should follow the timeline of laboratory monitoring, meaning refills should be made at weeks 4, 8, and 12, as appropriate to the treatment regimen. Thank you for allowing Project Inform and the National Viral Hepatitis Roundtable the opportunity to comment on the draft HCV treatment policy and express our concerns about the proposed policy. Please contact us if you have questions or require additional information. We look forward to your response to our concerns. Sincerely, Emalie Huriaux, MPH Tina Broder, MSW, MPH Director of Federal & State Affairs Program Manager Project Inform National Viral Hepatitis Roundtable (415) 580-7301 (510) 336-9613 cc: Ryan Clary, Executive Director, National Viral Hepatitis Roundtable Anne Donnolly, Director of Health Care Policy, Project Inform Margaret Tater, DHCS Neal Kohatsu, DHCS Anastasia Dodson, DHCS Mari Cantwell, DHCS